January 10, 2014
US-based beauty company Living Proof has signed a global joint venture with Canada-based Valeant Pharmaceuticals International to develop, distribute and sell aesthetic dermatology products. The transaction is worth over $75m, according to Living Proof. Some 60% of profits will go... 